NCT02100904View on ClinicalTrials.gov

Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry

Active, not recruitingOBSERVATIONAL
Enrollment

578

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Uterine Fibroids
Interventions
PROCEDURE

Radiofrequency ablation of fibroids

PROCEDURE

Myomectomy of fibroids

Trial Locations (12)

19904

Dedicated to Women, Dover

27704

Duke University, Durham

30005

Fibroid and Pelvic Wellness Center of Georgia, Alpharetta

60430

Women's Healthcare Associates of IL, SC, Homewood

60605

Gynecology Institute of Chicago, Chicago

75062

MacArthur Medical Center, Irving

75390

UT Southwestern, Dallas

78217

Acacia OBGYN, San Antonio

78723

Tassone Advanced Gynecology, Austin

92037

University of California, San Diego, San Diego

92868

UC Irvine Medical Center, Irvine

94115

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02100904 - Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry | Biotech Hunter | Biotech Hunter